Breast MRI

Breast MRI

State of the Art and Future Directions

Pinker, Katja; Partridge, Savannah; Mann, Ritse

Elsevier Science Publishing Co Inc

09/2022

644

Mole

Inglês

9780128227299

15 a 20 dias

Descrição não disponível.
Section 1. Performance and Interpretation of Breast MRI 1. Breast Magnetic Resonance Imaging Protocols i.Abbreviated and Ultrafast MRI ii.Multiparametric MRI in clinical practice 2. Artifacts 3. BI-RADS 4. The Kaiser score: an evidence-based clinical decision rule for dynamic contrast-enhanced breast MRI 5. Background parenchymal enhancement

Section 2. MRI Characteristics of Common Breast Lesions 6. Benign 7. High-risk 8. DCIS 9. Invasive cancers

Section 3. Clinical Indications for Breast MRI 10. Screening 11. Staging and treatment planning 12. Response assessment to neoadjuvant therapy 13. Follow-up: Posttreatment changes and Recurrent Breast Cancer 14. Breast Augmentation and Post-mastectomy Autologous Breast Reconstruction 15. Problem Solving 16. Cancer of Unknown Primary including Imaging of the Axilla

Section 4: Breast Magnetic Resonance Imaging-guided Interventions and Therapy 17. Biopsy including MRI-directed US and rad-path correlation 18. Monitoring Therapy Future Directons

Section 5. Advanced and Emerging Approaches 19. Non-contrast MRI 20. Ultra-high field magnets 21. Pharmacokinetic modelling 22. Diffusion MRI of the breast: standard and advanced techniques 23. Proton Magnetic Resonance Spectroscopy 24. Emerging MRI Techniques: CEST, BOLD, Sodium, Phospohorus MRS, Lipid MRS, HP MRI

Section 6: Hybrid Imaging and Alternative Techniques 25. PET/MRI hybrid imaging and targeted tracers 26. Alternative techniques: CEM and MBI

Section 7: Prognostic and Predictive MR imaging biomarkers 27. MRI Radiomics and Radiogenomics for Breast Cancer 28. Artificial Intelligence and Deep Learning
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Abscess; ACR BI-RADS; Apparent diffusion coefficient; Apparent diffusion coefficient (ADC); Architectural distortion; Assessment; Assessment category; Atlas; Atypical ductal hyperplasia; Autologous reconstruction; Avoid unnecessary biopsies; B3 lesion; Background parenchymal enhancement; Benign breast lesions; BI-RADS; BRCA1, BRCA2, and other hereditary breast cancer susceptibility genes; Breast cancer; Breast cancer risk; Breast cancer risk assessment; Breast cancer screening; Breast MRI; Breast-specific gamma imaging; Calcifications; CEST; Chemical exchange saturation transfer; Clinical decision rule; Contrast-enhanced mammography; Contrast-enhanced MRI; Core biopsy; Cryoablation; Decision tree; Deep learning; Diagnosis; DIEP flap; Diffusion Kurtosis Imaging (DKI); Diffusion tensor imaging (DTI); Diffusion-weighted imaging; Diffusion-weighted imaging (DWI); Diffusion-weighted magnetic resonance imaging; Digital breast tomosynthesis